BeOne Medicines AG (HKG:6160)
174.00
+9.90 (6.03%)
At close: Mar 27, 2026
BeOne Medicines AG Revenue
In the year 2025, BeOne Medicines AG had annual revenue of $5.34B USD with 40.23% growth. BeOne Medicines AG had revenue of $1.50B in the quarter ending December 31, 2025, with 32.84% growth.
Revenue
$5.34B
Revenue Growth
+40.23%
P/S Ratio
5.91
Revenue / Employee
$445.25K
Employees
12,000
Market Cap
245.81B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.34B | 1.53B | 40.23% |
| Dec 31, 2024 | 3.81B | 1.35B | 54.96% |
| Dec 31, 2023 | 2.46B | 1.04B | 73.65% |
| Dec 31, 2022 | 1.42B | 239.64M | 20.37% |
| Dec 31, 2021 | 1.18B | 867.41M | 280.83% |
| Dec 31, 2020 | 308.87M | -119.34M | -27.87% |
| Dec 31, 2019 | 428.21M | 229.99M | 116.03% |
| Dec 31, 2018 | 198.22M | -40.17M | -16.85% |
| Dec 31, 2017 | 238.39M | 237.32M | 22,179.16% |
| Dec 31, 2016 | 1.07M | -7.75M | -87.86% |
| Dec 31, 2015 | 8.82M | -4.22M | -32.37% |
| Dec 31, 2014 | 13.04M | 1.89M | 16.93% |
| Dec 31, 2013 | 11.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sino Biopharmaceutical | 35.43B |
| WuXi Biologics | 24.25B |
| Innovent Biologics | 14.51B |
| 3SBio | 9.94B |
| Shanghai Henlius Biotech | 7.42B |
| RemeGen | 3.62B |
| Akeso | 3.40B |
| Shanghai Junshi Biosciences | 2.78B |
BeOne Medicines AG News
- 4 weeks ago - BeOne Medicines: Guidance Weighs But Multiple Catalysts In 2026 - Seeking Alpha
- 4 weeks ago - BeOne Medicines AG (ONC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership - Business Wire
- 5 weeks ago - BeOne Medicines to Present at Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Prediction: These 3 Stocks Will Crush the Market in 2026 - The Motley Fool
- 6 weeks ago - BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26 - Business Wire
- 7 weeks ago - 3 Stocks to Buy in February - The Motley Fool
- 2 months ago - BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha